Short answer
BIOLIFE SOLUTIONS INC (BLFS) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $28M (up 12.0% year over year) with net income of $45M.
Q2 2026 key financials · XBRL
- Revenue
- $28M
- +12.0% YoY · +3.5% QoQ
- Net income
- $45M
- +384.8% YoY · +3703.0% QoQ
- Operating margin
- 6.0%
- Gross margin
- 64.2%
- EPS (diluted)
- $0.92
- +378.8% YoY · +4500.0% QoQ
Source: XBRL data from the BIOLIFE SOLUTIONS INC (BLFS) Q2 2026 10-Q on SEC EDGAR. USD.
BIOLIFE SOLUTIONS INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $28.5M, up $5.0M or 21% YoY, driven by biopreservation media demand
- Gross margin 64% vs 65% YoY, reflecting less favorable product mix and higher lower-margin sales
- Best-performing offering biopreservation media, with demand driving quarterly revenue growth
- Cash, equivalents and securities $113.1M vs $120.2M at December 31, 2025
- Six-month operating cash flow $5.9M vs $9.1M; $11.5M financing outflow included $6.7M tax-withholding payments
Risk Factors
- Risk factors section not provided; supplied text contains Items 2–6 and signatures only
- Merger agreement dated July 21, 2026, with Repligen Corporation and merger subsidiaries disclosed as an exhibit
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BIOLIFE SOLUTIONS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.